Clinical effects of istaroxime in acute heart failure and cardiogenic shock: A patient-level pooled analysis of four phase II randomized clinical trials.
Clinical takeaway The pooled findings support a haemodynamic signal for istaroxime, but do not establish a patient-centred outcome benefit. Clinical outcome effects require confirmation in a phase III trial.